Date published: 2026-2-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

DDX26B Inhibitoren

DDX26B Inhibitors constitute a specific class of chemical compounds designed to selectively impede the activity of the DDX26B enzyme. DDX26B, also known as DEAD-box helicase 26B, belongs to the broader family of DEAD-box helicases, which are involved in RNA metabolism and contribute to various aspects of RNA processing, including transcription, splicing, and translation. The development of inhibitors targeting DDX26B is pivotal for scientific exploration, offering specialized tools to elucidate the molecular functions and regulatory roles associated with this particular helicase. As a member of the DEAD-box helicase family, DDX26B likely plays a role in unwinding RNA secondary structures, facilitating RNA-protein interactions, and modulating the dynamic landscape of cellular RNA processing events.

The synthesis and optimization of DDX26B inhibitors necessitate a thorough understanding of the enzyme's structural features and its interactions within cellular pathways. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of DDX26B and interfere with its normal helicase activities. By utilizing DDX26B inhibitors in experimental settings, researchers can investigate the consequences of enzyme inhibition on RNA processing dynamics, shedding light on the specific substrates and molecular pathways governed by DDX26B. The study of DDX26B inhibitors contributes to the broader comprehension of cellular RNA metabolism, providing insights into the intricate molecular mechanisms that regulate gene expression and RNA-related processes in cells.

Siehe auch...

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
¥835.00
¥2742.00
¥8247.00
¥29017.00
¥246489.00
53
(3)

Actinomycin D bindet an die DNA, hemmt die Transkription und verhindert die Synthese von DDX26B mRNA.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
¥463.00
¥948.00
¥3103.00
127
(6)

Cycloheximid unterbricht die Proteinsynthese, was zu einer Verringerung der DDX26B-Expression durch Hemmung der Translation führt.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
¥474.00
¥2414.00
¥9387.00
¥745.00
394
(15)

Puromycin führt zu einer vorzeitigen Beendigung der Proteinsynthese, was sich auf die Translation auswirkt und den DDX26B-Spiegel senkt.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
¥1094.00
¥3700.00
¥7627.00
¥16551.00
6
(1)

Rifampicin hemmt die bakterielle RNA-Polymerase und unterdrückt dadurch indirekt die Expression von DDX26B, indem es die Transkription beeinträchtigt.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
¥1117.00
¥2922.00
36
(2)

Anisomycin hemmt die Proteinsynthese durch Blockierung der Peptidyltransferase-Aktivität, was zu einer verminderten DDX26B-Synthese führt.

Cordycepin

73-03-0sc-203902
10 mg
¥1139.00
5
(1)

Cordycepin greift in die mRNA-Synthese ein, beeinflusst die Transkription und trägt zur Herunterregulierung von DDX26B bei.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
¥778.00
¥3001.00
8
(1)

Mycophenolsäure hemmt die Inosinmonophosphat-Dehydrogenase und beeinträchtigt dadurch indirekt die Expression von DDX26B durch Störung der Purinsynthese.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
¥4140.00
¥5867.00
20
(2)

Blasticidin S induziert eine vorzeitige Terminierung während der Translation, hemmt die Proteinsynthese und reduziert den DDX26B-Spiegel.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
¥417.00
¥1715.00
11
(1)

5-Fluorouracil greift in die RNA-Synthese ein und beeinträchtigt die Expression von DDX26B, indem es die Produktion von mRNA unterbricht.